What is a bone sarcoma?

A bone sarcoma is a primary bone cancer—meaning the cancer starts within the bone tissue and forms a tumor. These tumors can develop in many areas of the body, most often in the arms, legs, and pelvis. Some bone sarcomas grow slowly, while others act more aggressively.

Many tumors found within bone tissue are benign (noncancerous). Bone sarcomas that are cancerous are actually quite uncommon, accounting for less than 1 percent of all diagnosed cancers.

Types of bone sarcoma

Our team provides care for all types of tumors found in the bones. Bone sarcomas include, but are not limited to:

  • Adamantinoma, a tumor most often found in the tibia (lower leg)
  • Angiosarcoma, an aggressive blood vessel tumor that can very rarely be found in the bone
  • Chondrosarcoma, a tumor that usually grows slowly, most often in the bones of the pelvis, humerus (upper arm), and femur (thigh)
  • Chordoma, a slow-growing tumor in the spine, primary at the base of the skull or lower spine (sacrum)
  • Ewing sarcoma, the second most common bone cancer in children and usually found in the bony pelvis as well as the femur and humerus
  • Leiomyosarcoma, a sarcoma that rarely starts in the bone
  • Osteosarcoma, the most common bone cancer in children and most commonly found around the bones of the knee as well as the humerus and pelvis
  • Undifferentiated pleomorphic sarcoma (UPS), a sarcoma that more commonly starts in the soft tissue but rarely can start in the bones

Bone cancer symptoms

People with bone sarcomas often feel constant pain that gets worse over time. Bone sarcomas can also break out of the bone into the surrounding soft tissues or lead to fractures. In the spine, they can press on nerves and cause pain.

Causes of bone sarcomas

The causes of most bone sarcomas are currently unknown, however researchers are continuing to study them.

In rare cases, radiation therapy and chemotherapy for other cancers can lead to the later development of bone cancer. Some people with noncancerous bone conditions called Paget disease may develop osteosarcoma.

Some genetic variants (changes), which are inherited, can be tied to rare syndromes. These syndromes cause various symptoms and diseases and can raise the risk for some cancers, including bone sarcomas. The genetic syndromes tied to higher bone cancer risk include:

  • Bloom syndrome: Osteosarcoma
  • Hereditary retinoblastoma: Osteosarcoma
  • Li-Fraumeni syndrome: Osteosarcoma
  • Multiple osteochondromas: Chondrosarcoma
  • Rothmund-Thomson syndrome II: Osteosarcoma
  • Tuberous sclerosis: Chordoma
  • Werner syndrome: Osteosarcoma

If one of these syndromes runs in your family, specialists at Penn Medicine can provide genetic testing and counseling.

Bone sarcoma diagnosis

A bone sarcoma diagnosis starts with imaging tests, usually an X-ray. If we require more images, we might order magnetic resonance imaging (MRI) as well. Our doctors may also recommend taking a sample of the suspected tumor during a biopsy, for our pathologists to examine.

Bone sarcoma diagnosis at Penn Medicine

Almost all bone sarcomas require surgery to remove them for the best overall result. For certain types of bone cancer, including Ewing sarcoma and osteosarcoma, chemotherapy before and after surgery will be required. Ewing sarcoma is a type of sarcoma in the bone that can be treated with either radiation or surgery in addition to the chemotherapy. Chondrosarcomas and chordomas do not respond to chemotherapy or immunotherapy.

Radiation therapy is used in combination with surgery for the treatment of chordoma in the lower spine or at the bottom of the skull. An advanced, highly accurate form of radiation called proton therapy may help in those cases. Occasionally, high-dose radiation is used alone for the treatment of chordoma in certain situations.

Because bone sarcoma is a cancer, it has the possibility to metastasize (spread). For these tumors, we have the expertise to provide a range of treatment options, including emerging therapies only available through clinical trials.

Treating bone sarcoma

National Cancer Institute "Designated Comprehensive Cancer Center" badge on top of exterior shot of the Perelman Center for Advanced Medicine

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Related specialties

Patient stories

Tool measures tumor growth for less uncertainty between scans

Neuroradiologists have developed the first-ever tool that gives a real-time assessment of an individual’s tumor, and relieves anxiety between scans.

In the face of skin cancer, proton made all the difference

A Lancaster man and father of two reveals how proton therapy helped him beat skin cancer and reclaim his life.

A grateful patient pays it forward to treat uterine cancers

Dalia Jakas credits her doctor with curing her uterine cancer without harming her quality of life. Now, she’s paying it forward for future patients.

Patient puts national spotlight on cancer clinical trials

As Kate Korson recently shared on Good Morning America, both she and her mother participated in clinical trials at Abramson Cancer Center.

Redefining the cancer bell to celebrate with meaning

The Abramson Cancer Center wants to make bell-ringing more inclusive, so cancer patients can recognize their moments to cheer, large and small.

CNN anchor Kasie Hunt had brain surgery at Penn

Before starting her own daily news show, journalist Kasie Hunt came to Penn Medicine for a growing brain tumor that was causing painful headaches.

How pickleball (and Penn Medicine) saved one patient’s life

With teamwork and determination, specialists at Penn Medicine solved Ronnie Recchia’s life-threatening medical mystery and got him back in the game.

A community hospital is a destination for cancer care

At Lancaster General Health, receiving advanced treatments closer to home has changed the battle with cancer for patients across central Pennsylvania.

Finding triple-negative breast cancer at 33, she chose ‘Team Penn’

Shocked to learn she had stage III breast cancer, Kate Korson knew just where to go. She flew home to Penn Medicine, where a clinical trial saved her life.

Finding relief from decades of jaw pain

Marie experienced intense pain due to an inherited condition and injuries. Penn Medicine’s TMJ program helped her find relief.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.